Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

This podcast contains general information for educational purposes only. This is not professional

advice and should not be used in lieu of obtaining advice from a qualified health care provider.

And now on to the show.

Welcome to Helix Talk episode 107. I'm your co-host Dr. King. And I'm Dr. Patel. And the title of

today's episode is You're Going going to go bananas over this brief review

of hypercalemia.

And in this episode, we're going to be covering some typical treatment approaches to both

acute and chronic hypercalemia.

So first and foremost, let's define what is hypercalaemia, right?

It's sometime all about the numbers.

So talking about the serum potassium, generally above 5.5 milliculin pelleter would be considered

elevated potassium or hypercilemia, although institution-specific thresholds are different.

Sometimes I've seen some studies Dr. Kane chronic hypercalemia is defined as 5.1

and above. So it really depends on the institution. And it probably also depends on your patient's

renal function as an example, where you might be less inclined to tolerate a slightly higher potassium

level in someone with chronic kidney disease because they're more prone to getting that hypercalemia,

especially if you're titrating meds that will cause more hypercalemia.

The thresholds for starting the treatment is a little bit higher.

So, yeah, we watch the potassium if it's, you know, 5.5 or 5.1 and above.

But really, when it gets to the level where it surmounts to some signs and symptoms are some of those higher levels.

...